Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

PPR Control in a Sahelian Setting: What Vaccination Strategy for Mauritania?

ElArbi AS, Kane Y, Metras R, Hammami P, Ciss M, Beye A, Lancelot R, Diallo A, Apolloni A.

Front Vet Sci. 2019 Jul 23;6:242. doi: 10.3389/fvets.2019.00242. eCollection 2019.

2.

Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study.

Colombi D, Serra-Cobo J, Métras R, Apolloni A, Poletto C, López-Roig M, Bourhy H, Colizza V.

Sci Rep. 2019 Jan 24;9(1):537. doi: 10.1038/s41598-018-36485-y.

3.

Unexpected field observations and transmission dynamics of contagious caprine pleuropneumonia in a sand gazelle herd.

Lignereux L, Chaber AL, Saegerman C, Manso-Silván L, Peyraud A, Apolloni A, Thiaucourt F.

Prev Vet Med. 2018 Sep 1;157:70-77. doi: 10.1016/j.prevetmed.2018.06.002. Epub 2018 Jun 13.

PMID:
30086851
4.

Predictive gravity models of livestock mobility in Mauritania: The effects of supply, demand and cultural factors.

Nicolas G, Apolloni A, Coste C, Wint GRW, Lancelot R, Gilbert M.

PLoS One. 2018 Jul 18;13(7):e0199547. doi: 10.1371/journal.pone.0199547. eCollection 2018.

5.

Towards the description of livestock mobility in Sahelian Africa: Some results from a survey in Mauritania.

Apolloni A, Nicolas G, Coste C, El Mamy AB, Yahya B, El Arbi AS, Gueya MB, Baba D, Gilbert M, Lancelot R.

PLoS One. 2018 Jan 24;13(1):e0191565. doi: 10.1371/journal.pone.0191565. eCollection 2018.

6.

Ecological distribution and population dynamics of Rift Valley fever virus mosquito vectors (Diptera, Culicidae) in Senegal.

Biteye B, Fall AG, Ciss M, Seck MT, Apolloni A, Fall M, Tran A, Gimonneau G.

Parasit Vectors. 2018 Jan 9;11(1):27. doi: 10.1186/s13071-017-2591-9.

7.

Drivers of Rift Valley fever epidemics in Madagascar.

Lancelot R, Béral M, Rakotoharinome VM, Andriamandimby SF, Héraud JM, Coste C, Apolloni A, Squarzoni-Diaw C, de La Rocque S, Formenty PB, Bouyer J, Wint GR, Cardinale E.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):938-943. doi: 10.1073/pnas.1607948114. Epub 2017 Jan 17.

8.

The Topology of a Discussion: The #Occupy Case.

Gargiulo F, Bindi J, Apolloni A.

PLoS One. 2015 Sep 9;10(9):e0137191. doi: 10.1371/journal.pone.0137191. eCollection 2015.

9.

A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.

Lin MH, Apolloni A, Cutillas V, Sivakumaran H, Martin S, Li D, Wei T, Wang R, Jin H, Spann K, Harrich D.

J Virol. 2015 May;89(9):4827-36. doi: 10.1128/JVI.03440-14. Epub 2015 Feb 11.

10.

Metapopulation epidemic models with heterogeneous mixing and travel behaviour.

Apolloni A, Poletto C, Ramasco JJ, Jensen P, Colizza V.

Theor Biol Med Model. 2014 Jan 13;11:3. doi: 10.1186/1742-4682-11-3.

11.

The diminishing role of hubs in dynamical processes on complex networks.

Quax R, Apolloni A, Sloot PM.

J R Soc Interface. 2013 Sep 4;10(88):20130568. doi: 10.1098/rsif.2013.0568. Print 2013 Nov 6.

12.

Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6.

Sivakumaran H, Lin MH, Apolloni A, Cutillas V, Jin H, Li D, Wei T, Harrich D.

Virol J. 2013 Jun 24;10:207. doi: 10.1186/1743-422X-10-207.

13.

Analysis of Friendship Network and its Role in Explaining Obesity.

Marathe A, Pan Z, Apolloni A.

ACM Trans Intell Syst Technol. 2013 Jun;4(3). doi: 10.1145/2483669.2483689.

14.

Age-specific contacts and travel patterns in the spatial spread of 2009 H1N1 influenza pandemic.

Apolloni A, Poletto C, Colizza V.

BMC Infect Dis. 2013 Apr 15;13:176. doi: 10.1186/1471-2334-13-176.

15.

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

Apolloni A, Lin MH, Sivakumaran H, Li D, Kershaw MH, Harrich D.

Hum Gene Ther. 2013 Mar;24(3):270-82. doi: 10.1089/hum.2012.176. Epub 2013 Mar 1.

16.

Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking.

Lin MH, Sivakumaran H, Apolloni A, Wei T, Jans DA, Harrich D.

PLoS One. 2012;7(12):e51466. doi: 10.1371/journal.pone.0051466. Epub 2012 Dec 10.

17.

Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors.

Warren K, Wei T, Li D, Qin F, Warrilow D, Lin MH, Sivakumaran H, Apolloni A, Abbott CM, Jones A, Anderson JL, Harrich D.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9587-92. doi: 10.1073/pnas.1204673109. Epub 2012 May 24.

18.

Distribution of vaccine/antivirals and the 'least spread line' in a stratified population.

Goldstein E, Apolloni A, Lewis B, Miller JC, Macauley M, Eubank S, Lipsitch M, Wallinga J.

J R Soc Interface. 2010 May 6;7(46):755-64. doi: 10.1098/rsif.2009.0393. Epub 2009 Oct 14.

19.

Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat.

Sivakumaran H, van der Horst A, Fulcher AJ, Apolloni A, Lin MH, Jans DA, Harrich D.

J Virol. 2009 Nov;83(22):11694-703. doi: 10.1128/JVI.00499-09. Epub 2009 Sep 2.

20.

X-ray and gamma-ray propagation in bent crystals with flat and cylindrical surfaces.

Apolloni A, Mana G, Palmisano C, Zosi G.

Acta Crystallogr A. 2008 Sep;64(Pt 5):549-59. doi: 10.1107/S0108767308021508. Epub 2008 Aug 14.

PMID:
18708718
21.

The HIV-1 Tat protein stimulates reverse transcription in vitro.

Apolloni A, Meredith LW, Suhrbier A, Kiernan R, Harrich D.

Curr HIV Res. 2007 Sep;5(5):473-83.

PMID:
17896967
22.

Protein methylation is required to maintain optimal HIV-1 infectivity.

Willemsen NM, Hitchen EM, Bodetti TJ, Apolloni A, Warrilow D, Piller SC, Harrich D.

Retrovirology. 2006 Dec 15;3:92.

23.

Will diverse Tat interactions lead to novel antiretroviral drug targets?

Harrich D, McMillan N, Munoz L, Apolloni A, Meredith L.

Curr Drug Targets. 2006 Dec;7(12):1595-606. Review.

PMID:
17168834
25.

Human immunodeficiency virus type 1 reverse transcription is stimulated by tat from other lentiviruses.

Hooker CW, Scott J, Apolloni A, Parry E, Harrich D.

Virology. 2002 Sep 1;300(2):226-35.

26.

Characterization of RasGRP2, a plasma membrane-targeted, dual specificity Ras/Rap exchange factor.

Clyde-Smith J, Silins G, Gartside M, Grimmond S, Etheridge M, Apolloni A, Hayward N, Hancock JF.

J Biol Chem. 2000 Oct 13;275(41):32260-7.

27.

H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway.

Apolloni A, Prior IA, Lindsay M, Parton RG, Hancock JF.

Mol Cell Biol. 2000 Apr;20(7):2475-87.

28.

Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains.

Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E, Rolls B, Hancock JF, Parton RG.

Nat Cell Biol. 1999 Jun;1(2):98-105.

PMID:
10559881
29.

Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase.

Yan J, Roy S, Apolloni A, Lane A, Hancock JF.

J Biol Chem. 1998 Sep 11;273(37):24052-6.

30.

14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo.

Roy S, McPherson RA, Apolloni A, Yan J, Lane A, Clyde-Smith J, Hancock JF.

Mol Cell Biol. 1998 Jul;18(7):3947-55.

31.

Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.

Apolloni A, Sculley TB.

Virology. 1994 Aug 1;202(2):978-81.

PMID:
8030259
32.

Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus.

Apolloni A, Moss D, Stumm R, Burrows S, Suhrbier A, Misko I, Schmidt C, Sculley T.

Eur J Immunol. 1992 Jan;22(1):183-9.

PMID:
1370413
33.

Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma.

Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA.

Blood. 1991 Dec 1;78(11):3004-11.

34.

Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.

Moss DJ, Misko IS, Sculley TB, Apolloni A, Khanna R, Burrows SR.

Springer Semin Immunopathol. 1991;13(2):147-56. Review. No abstract available.

PMID:
1724100
35.

Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA.

J Infect Dis. 1990 Sep;162(3):643-8.

PMID:
2167337
36.

Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.

Sculley TB, Apolloni A, Stumm R, Moss DJ, Mueller-Lantczh N, Misko IS, Cooper DA.

Virology. 1989 Aug;171(2):401-8.

PMID:
2548326
37.

Respite services in California: status and recommendations for improvement.

Apolloni AH, Triest G.

Ment Retard. 1983 Dec;21(6):240-3. No abstract available.

PMID:
6231448

Supplemental Content

Loading ...
Support Center